Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00003381
DRKS00003381
Recruiting
Not Applicable

Susceptibility to respiratory tract infections - AWIS

niversitätsklinikum Freiburg0 sites1,500 target enrollmentDecember 8, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsATEMWEGSINFEKTANFLLIGKEITJ00J01J02J03J04J05J06J12J13J14J15J16J17J18J20J21J22Acute nasopharyngitis [common cold]Acute sinusitisAcute pharyngitisAcute tonsillitisAcute laryngitis and tracheitisAcute obstructive laryngitis [croup] and epiglottitisAcute upper respiratory infections of multiple and unspecified sitesViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedAcute bronchitisAcute bronchiolitisUnspecified acute lower respiratory infection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ATEMWEGSINFEKTANFLLIGKEIT
Sponsor
niversitätsklinikum Freiburg
Enrollment
1500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 8, 2011
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Screening study (step 1\)
  • •20\-70 years of age
  • •\- comprehension of German language
  • •\- resident of Freiburg and Breisgau/Hochschwarzwald
  • •\- consent for participation in questionnaire study.
  • •Supplementary study (step 2\):
  • •same as above
  • •\- lack of indicated co\-morbidities
  • •\- consent for participation in supplementary study including consent to 1\) provide a saliva samples as source of genomic DNA, 2\) to allow study nurse to contact participant and primary care physician to validate phenotype
  • •\- highest 7\.5% of RTI score (group 1\)

Exclusion Criteria

  • •Screening study:
  • •\- Residence outside study region
  • •\- non\-comprehension of German language
  • •\- lack of consent
  • •Supplementary study:
  • •same as above
  • •\- prevalence of indicated co\-morbidities
  • •\- lack of consent for supplementary study
  • •\- RTI score outside range of interest

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Infections of lungs in a COVID patients with symptoms and detection of its antibiotic sensitivity .Health Condition 1: J128- Other viral pneumoniaHealth Condition 2: J22- Unspecified acute lower respiratory infectionHealth Condition 3: J22- Unspecified acute lower respiratory infectionHealth Condition 4: J22- Unspecified acute lower respiratory infectionHealth Condition 5: J22- Unspecified acute lower respiratory infection
CTRI/2021/01/030679AIIMS Rishikesh
Completed
Not Applicable
Subclinical infections of the respiratory tract affecting CVID patientsD83J47Common variable immunodeficiencyBronchiectasis
DRKS00009704niversitätsklinikum Freiburg70
Not yet recruiting
Not Applicable
A study of organisms causing respiratory tract infections in ICU patients focusing on Acinetobacter baumanniiHealth Condition 1: J22- Unspecified acute lower respiratory infection
CTRI/2024/02/062637Medha
Not yet recruiting
Not Applicable
Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivityHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/04/024636DACH Jaipur
Completed
Not Applicable
Microbiome and lower respiratory tract infections in childrebronchitis or pneumoniaLower respiratory tract infections10019815
NL-OMON44725Spaarne Ziekenhuis975